Telomir Pharmaceuticals, Inc. Common Stock ( TELO) - Stock Earnings
TELO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.1 million USD | — USD |
| 2026Q1 | -990947 USD | — USD |
| 2026Q2 | -1.7 million USD | — USD |
| 2026Q4 Est. | — | — |
TELO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.1 million USD | — USD |
| 2024 | -16.5 million USD | — USD |
| 2025 | -10.4 million USD | — USD |
| 2026 Est. | — | — |
TELO
Price: $1.05
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 81.2 million